Cp10 peptide is an established research compound evaluated in preclinical models for its role in cellular signaling, leukocyte recruitment, and innate immune cascades. This technical overview provides laboratory researchers with an in-depth analysis of its biochemical profile, receptor dynamics, reconstitution parameters, and strict analytical quality benchmarks.
Cp10 peptide is an established research compound evaluated in preclinical models for its role in cellular signaling, leukocyte recruitment, and innate immune cascades. This technical overview provides laboratory researchers with an in-depth analysis of its biochemical profile, receptor dynamics, reconstitution parameters, and strict analytical quality benchmarks.
Cp10 peptide (Chemotactic Peptide 10) is a specialized synthetic research compound derived from the C-terminal sequence of S100A8 (calgranulin A), a calcium-binding protein belonging to the S100 family. In physiological systems, S100A8 forms heterodimers with S100A9, acting as a key mediator in inflammatory responses and cellular recruitment. The isolated Cp10 sequence represents the primary domain responsible for orchestrating potent chemotactic responses in myeloid lineage cells.
Synthesized for in vitro and laboratory research, Cp10 peptide exhibits high affinity for specific cell-surface receptors on neutrophils and macrophages. In structural assays, the peptide maintains a defined conformation that allows researchers to isolate the chemotactic signaling pathways of S100 proteins without the confounding variables associated with full-length protein multi-merization. Understanding the precise molecular weight, amino acid sequence, and steric constraints of Cp10 is essential when designing controlled cell migration and signal transduction experiments.
Preclinical studies suggest that Cp10 peptide operates predominantly through GPCR (G-protein coupled receptor) signaling pathways, triggering downstream intracellular calcium mobilization and protein kinase C (PKC) activation. In vitro assays demonstrate that exposure of murine and human neutrophils to nanomolar concentrations of Cp10 induces rapid actin polymerization, cell polarization, and directed migration across endothelial barriers.
In addition to cell motility, laboratory research indicates that Cp10 peptide modulates the expression of adhesion molecules such as CD11b/CD18 (Mac-1) on the surface of circulating leukocytes. This upregulation facilitates firm adhesion to vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) in microvascular endothelial culture models. Through these distinct pathways, researchers utilize Cp10 as a tool compound to dissect the early phase kinetics of host defense and acute cellular recruitment.
Within the domain of immunology, Cp10 peptide serves as a valuable model molecule for examining inflammatory cascade resolution and leukocyte traffic. Animal study models investigating acute tissue injury employ Cp10 to induce localized, highly predictable neutrophil infiltration, allowing scientists to evaluate the efficacy of novel anti-inflammatory agents or innate immune inhibitors.
Furthermore, in vitro data indicate that Cp10 peptide exerts dose-dependent effects on reactive oxygen species (ROS) generation and chemokine release from activated macrophages. Researchers investigating the dual roles of S100 alarmins in tissue repair and chronic inflammation frequently utilize high-purity cp10 peptide to compare its specific signaling output against broad-spectrum inflammatory stimuli like lipopolysaccharide (LPS).
When designing comparative cell-signaling assays, investigators frequently evaluate Cp10 alongside other potent immune-modulating peptides in our comprehensive catalog of all peptides. For instance, while Cp10 specifically models S100A8-driven myeloid chemotaxis via GPCR activation, the antimicrobial peptide LL-37 acts via membrane disruption and formyl peptide receptor 2 (FPR2) signaling. Similarly, Thymosin Alpha-1 targets Toll-like receptors (TLRs) to modulate broader T-cell and dendritic cell maturation pathways.
In tissue regeneration models, researchers also contrast the leukocyte-recruiting activity of Cp10 with the cytoprotective signaling observed in studies evaluating BPC-157 research overview. Selecting the appropriate compound depends on whether the laboratory objective is to trigger localized leukocyte extravasation (Cp10), stimulate antimicrobial membrane permeability (LL-37), or promote localized angiogenic pathway expression.
Successful implementation of Cp10 peptide in laboratory assays requires precise control over experimental variables such as buffer composition, temperature, and cell density. In standard Boyden chamber or microfluidic migration assays, Cp10 is typically evaluated across a concentration gradient ranging from 10^-11 M to 10^-7 M to establish sigmoidal dose-response curves for cell directional velocity.
To prevent non-specific adsorption of the peptide to plasticware during serial dilutions, research protocols frequently mandate the addition of 0.1% low-endotoxin bovine serum albumin (BSA) or heat-inactivated fetal bovine serum (FBS) to the assay media. Researchers analyzing downstream phosphorylation events via Western blot or flow cytometry should freeze cellular lysates immediately post-stimulation to capture transient kinase activation peaks.
Cp10 peptide is supplied as a lyophilized, sterile powder designed exclusively for laboratory research use. To maintain peptide integrity, reconstitution should be performed inside a certified laminar flow hood using sterile, endotoxin-free water or sterile phosphate-buffered saline (PBS, pH 7.4).
A standard reconstitution protocol involves adding the appropriate volume of solvent to the inner vial wall, followed by gentle swirling or inversion. Gentle manual agitation is recommended; high-speed vortexing or vigorous shaking should be strictly avoided as shear forces can induce peptide denaturation or aggregation. For detailed handling workflows across various experimental matrices, scientists can consult our centralized research library hub.
In its original lyophilized state, Cp10 peptide exhibits superior physicochemical stability when stored at -20°C or -80°C in a desiccated environment protected from direct light exposure. Under these conditions, the peptide maintains its specified purity profile for extended periods.
Once reconstituted into an aqueous solution, stock aliquots should be divided into single-use working volumes to prevent damaging freeze-thaw cycles. Reconstituted solution aliquots are typically stable at -80°C for up to 3 to 6 months. Working solutions maintained at 4°C should be utilized within 24 to 48 hours to minimize degradation or bacterial contamination risk.
Rigorous research outcomes require absolute confidence in compound purity, sequence accuracy, and batch-to-batch consistency. Substandard or contaminated research peptides introduce confounding variables that invalidate assay data. PX1 Research ensures all synthesized materials undergo comprehensive analytical evaluation at our USA-based, ISO 17025 accredited facility.
Every lot of Cp10 peptide is verified via reverse-phase high-performance liquid chromatography (RP-HPLC) to guarantee a chemical purity exceeding 98%. Mass spectrometry (MS) analysis is performed concurrently to confirm exact molecular weight and sequence fidelity. Furthermore, chromogenic LAL assays are conducted to enforce stringent endotoxin limits (<0.01 EU/μg), ensuring the compound does not provoke non-specific background responses in sensitive cell cultures.
PX1 Research is dedicated to supplying the scientific community with fully characterized, USA-manufactured research peptides. Operating from state-of-the-art facilities in California and Arizona, we maintain strict adherence to GMP-compliant manufacturing standards and lot-specific traceability protocols.
Principal investigators and procurement specialists seeking dedicated supply lines for ongoing preclinical projects can establish direct accounts via our wholesale lab portal. Every shipment includes a lot-specific Certificate of Analysis (COA) detailing HPLC chromatograms, mass spectra, and endotoxin assay results, backed by same-day dispatch for orders placed Monday through Friday.
What is the primary research focus when studying Cp10 peptide?
Cp10 peptide is primarily investigated in preclinical laboratory settings to study leukocyte chemotaxis, neutrophil activation, macrophage recruitment, and the signaling cascades associated with the S100A8 protein family during early-phase inflammatory responses.
How is the purity of PX1 Research Cp10 peptide verified?
Every lot of Cp10 peptide manufactured by PX1 Research undergoes rigorous testing in an ISO 17025 laboratory. Purity (>98%) is confirmed via reverse-phase HPLC, molecular identity is verified by mass spectrometry (MS), and endotoxin levels are quantified using chromogenic LAL testing.
What solvent is recommended for reconstituting Cp10 peptide?
For most in vitro assays, lyophilized Cp10 peptide should be reconstituted in sterile, endotoxin-free water or sterile phosphate-buffered saline (PBS, pH 7.4). The addition of 0.1% carrier protein (such as low-endotoxin BSA) is recommended if serial dilutions are planned.
What are the recommended storage conditions for reconstituted Cp10 peptide?
Reconstituted stock solutions should be divided into single-use aliquots and stored at -80°C to minimize degradation and avoid repeated freeze-thaw cycles. Diluted working solutions kept at 4°C should be used within 24–48 hours.
What is the endotoxin limit enforced on PX1 Research compounds?
PX1 Research enforces an industry-leading endotoxin limit of less than 0.01 EU/μg on all research-grade peptides. This ensures that observed cellular responses are driven solely by the active peptide rather than bacterial contaminants.
How does Cp10 peptide compare to LL-37 in cellular research?
While Cp10 peptide acts primarily as a targeted chemotactic agonist for myeloid cells via GPCR signaling, LL-37 is an antimicrobial peptide that modulates immune responses via membrane permeability changes and FPR2 activation.
Are PX1 Research peptides suitable for human administration?
No. All products supplied by PX1 Research, including Cp10 peptide, are strictly intended for laboratory research, in vitro studies, and preclinical scientific investigation. They are never for human consumption, clinical use, or diagnostic procedures.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.